Recent Dealmaking (05/2003)
Executive Summary
Summarizing the month in European dealmaking.
You may also be interested in...
Algae With Claimed Immunity Benefits Gets EU Nod For Supplement Use
An algae extract that is claimed to support the immune system while helping to protect against oxidative stress has obtained a positive opinion as a novel food in the European Union.
Is It Time To Promote US FDA’s Biosimilars Office Out Of OND?
Making the Office of Therapeutic Biologics and Biosimilars a stand-alone office in CDER may allow it to add more expertise, but is there an appetite for another reorganization?
UK LifeSci Funding Boost – Medtech Research And Regulation To Benefit
Rebranded Health Innovation Networks, Biobanks and clinical trials get share of £650m UK funding earmarked to support research, manufacturing, skills development and access to diagnosis and treatment.